StockData
Seres Therapeutics, Inc. logo

Seres Therapeutics, Inc. (MCRB) stock

MCRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$1.44+0.03 (+2.13%)

Close on Nov 18, 2026Market cap $14.32MP/E –Yield –

Seres Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Seres Therapeutics's revenue for the twelve months ending Jun 30, 2026 was $1.88M. For fiscal 2025 it was $789.00K. The highest annual figure on record is $144.93M in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$789.00K–
FY2024Dec 31, 2024$0–
FY2023Dec 31, 2023$0-100.0%
FY2022Dec 31, 2022$7.13M-95.1%
FY2021Dec 31, 2021$144.93M+336.3%
FY2020Dec 31, 2020$33.22M-3.7%
FY2019Dec 31, 2019$34.51M+22.1%
FY2018Dec 31, 2018$28.27M-11.9%
FY2017Dec 31, 2017$32.10M+47.5%
FY2016Dec 31, 2016$21.77M–
FY2015Dec 31, 2015$0–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$736.00K–
Q1 FY2026Mar 31, 2026$358.00K–
Q4 FY2025Dec 31, 2025$438.00K–
Q3 FY2025Sep 30, 2025$351.00K–
Q2 FY2025Jun 30, 2025$0–
Q1 FY2025Mar 31, 2025$0–
Q4 FY2024Dec 31, 2024$0-100.0%
Q3 FY2024Sep 30, 2024$0-100.0%
Q2 FY2024Jun 30, 2024$0-100.0%
Q1 FY2024Mar 31, 2024$0–
Q4 FY2023Dec 31, 2023$64.00K-93.4%
Q3 FY2023Sep 30, 2023$310.00K-91.0%
Q2 FY2023Jun 30, 2023$126.47M+10300.7%
Q1 FY2023Mar 31, 2023-$522.00K-135.0%
Q4 FY2022Dec 31, 2022$975.00K-86.5%
Q3 FY2022Sep 30, 2022$3.44M-97.3%
Q2 FY2022Jun 30, 2022$1.22M-76.9%
Q1 FY2022Mar 31, 2022$1.49M-73.9%
Q4 FY2021Dec 31, 2021$7.22M-58.9%
Q3 FY2021Sep 30, 2021$126.73M+8843.2%
Q2 FY2021Jun 30, 2021$5.26M-12.9%
Q1 FY2021Mar 31, 2021$5.72M-30.2%
Q4 FY2020Dec 31, 2020$17.56M+130.4%
Q3 FY2020Sep 30, 2020$1.42M-79.8%
Q2 FY2020Jun 30, 2020$6.05M-51.8%
Q1 FY2020Mar 31, 2020$8.19M+11.9%
Q4 FY2019Dec 31, 2019$7.62M-28.3%
Q3 FY2019Sep 30, 2019$7.03M-22.4%
Q2 FY2019Jun 30, 2019$12.53M+171.7%
Q1 FY2019Mar 31, 2019$7.32M+84.4%
Q4 FY2018Dec 31, 2018$10.63M+247.8%
Q3 FY2018Sep 30, 2018$9.06M-60.7%
Q2 FY2018Jun 30, 2018$4.61M+53.0%
Q1 FY2018Mar 31, 2018$3.97M+31.7%
Q4 FY2017Dec 31, 2017$3.06M+0.7%
Q3 FY2017Sep 30, 2017$23.02M+76.8%
Q2 FY2017Jun 30, 2017$3.01M–
Q1 FY2017Mar 31, 2017$3.02M–
Q4 FY2016Dec 31, 2016$3.04M–
Q3 FY2016Sep 30, 2016$13.02M–

More Seres Therapeutics figures

See a number that looks wrong?